Before NTZ treatment, MS patients showed significantly higher OPN levels in plasma than HC (Figure 9A), and MS patients normalized OPN levels to those found in HC after NTZ treatment (between 6 and 12 months, Figure 9B). Here, SPP1 is linked to myeloid sarcoma.